Emmaus: ‘We Might Stand A Better Chance In Europe Without The EMA’

The company will need new data if it uses the decentralized route For Xyndari

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".